Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb: Firm's revenues expected to grow in mid-single digits in FY 2004 based on continued strong sales from contact lens, lens care, pharmaceuticals categories, CEO Frank Zarrella projects during Oct. 30 earnings call. For the third quarter ended Sept. 27, B&L records 7.5% increase in lens care sales to $131.2 mil. as the ReNu brand continued to post impressive gains. Overall third quarter sales rose 9% to $508.8 mil.; net earnings totaled $32.3 mil. versus $9.4 mil. last year...

You may also be interested in...



Ester-E launch

Enhanced supplement Ester-E will begin rolling out in late spring 2004, Zila announces. The promotional campaign will begin at launch with national radio ads featuring spokesperson Larry King, and expand to television and print later in the year. A clinical trial measuring cardiovascular health as the primary endpoint is set to commence in May. Zila's Ester-E technology is based on a patented process for manufacturing tocopherol phosphate, obtained from Australia-based Vital Health Sciences. Zila recorded a 36% revenue increase on the strength of Ester-C sales in the fourth quarter ended July 31 (1"The Tan Sheet" Nov. 3, 2003, p. 15)...

Ester-E launch

Enhanced supplement Ester-E will begin rolling out in late spring 2004, Zila announces. The promotional campaign will begin at launch with national radio ads featuring spokesperson Larry King, and expand to television and print later in the year. A clinical trial measuring cardiovascular health as the primary endpoint is set to commence in May. Zila's Ester-E technology is based on a patented process for manufacturing tocopherol phosphate, obtained from Australia-based Vital Health Sciences. Zila recorded a 36% revenue increase on the strength of Ester-C sales in the fourth quarter ended July 31 (1"The Tan Sheet" Nov. 3, 2003, p. 15)...

Ester-E launch

Enhanced supplement Ester-E will begin rolling out in late spring 2004, Zila announces. The promotional campaign will begin at launch with national radio ads featuring spokesperson Larry King, and expand to television and print later in the year. A clinical trial measuring cardiovascular health as the primary endpoint is set to commence in May. Zila's Ester-E technology is based on a patented process for manufacturing tocopherol phosphate, obtained from Australia-based Vital Health Sciences. Zila recorded a 36% revenue increase on the strength of Ester-C sales in the fourth quarter ended July 31 (1"The Tan Sheet" Nov. 3, 2003, p. 15)...

Related Content

Topics

UsernamePublicRestriction

Register

PS096124

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel